Pleun De Groen

Amsterdam, NH 1066EC, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Early-Life Gut Microbiota: Education of the Immune System and Links to Autoimmune Diseases.

Early-Life Gut Microbiota: Education of the Immune System and Links to Autoimmune Diseases.

Journal: Microorganisms

Published: October 30, 2025

Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetes.

Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetes.

Journal: Gut microbes

Published: October 06, 2025

Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies.

Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies.

Journal: International journal of molecular sciences

Published: September 29, 2025

Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitus.

Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitus.

Journal: Diabetes, obesity & metabolism

Published: May 19, 2025

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis.

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis.

Journal: BMJ open

Published: January 09, 2025

Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort study.

Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort study.

Journal: The lancet. Diabetes & endocrinology

Published: January 03, 2025

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.

Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.

Journal: Diabetologia

Published: January 12, 2024

Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.

Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.

Journal: European journal of endocrinology

Published: July 25, 2023

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.

Journal: Diabetes care

Published: April 30, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026